Side-by-side comparison: effects, dosing ranges, side effects, regulatory status, and reconstitution.
Peptide A
Healing & Recovery
Synthetic fragment of Thymosin Beta-4 with potent tissue repair activity.
Peptide B
Peptide Blends
The classic recovery stack — BPC-157 paired with TB-500 for accelerated tissue repair.
Typical vial
5 mg
Typical dose
2000-5000 mcg
Half-life
~6-8 hours
FDA status
Not FDA approved for human use.
Typical vial
20 mg
Typical dose
250 + 2000 (BPC + TB) mcg
Half-life
BPC-157 ~4 h; TB-500 ~6-8 h
FDA status
Neither component is FDA approved for human use. FDA issued …
TB-500 effects
Wolverine Blend (BPC-157 + TB-500) effects
TB-500 side effects
Wolverine Blend (BPC-157 + TB-500) side effects
TB-500 dosing ranges
Acute injury healing
2000-5000 mcg · Twice weekly · 4-6 weeks
Maintenance and recovery
2000 mcg · Once weekly · 4-8 weeks
Wolverine Blend (BPC-157 + TB-500) dosing ranges
Acute soft-tissue injury (loading)
250-500 mcg BPC + 2-5 mg TB-500 · BPC daily, TB-500 twice weekly · 4-6 weeks
Chronic tendinopathy
250 mcg BPC + 2 mg TB-500 · BPC daily, TB-500 weekly · 6-8 weeks
Maintenance after recovery
250 mcg BPC + 2 mg TB-500 · BPC 3-4x weekly, TB-500 fortnightly · 4 weeks
TB-500: Synthetic fragment of Thymosin Beta-4 with potent tissue repair activity. Typical dose 2000-5000 mcg. Wolverine Blend (BPC-157 + TB-500): The classic recovery stack — BPC-157 paired with TB-500 for accelerated tissue repair. Typical dose 250 + 2000 (BPC + TB) mcg. Both fall under the Healing & Recovery and Peptide Blends categories.
Stacking TB-500 with Wolverine Blend (BPC-157 + TB-500) is a protocol-design question best raised with a clinician — it depends on your goal, current bloodwork, and whether both peptides target overlapping mechanisms. Both peptides should be tracked independently with separate injection sites and timing. PinnyPeptide supports multi-peptide stacks with automatic injection site rotation.
TB-500 is typically dosed: Twice weekly for Acute injury healing; Once weekly for Maintenance and recovery. Wolverine Blend (BPC-157 + TB-500) is typically dosed: BPC daily, TB-500 twice weekly for Acute soft-tissue injury (loading); BPC daily, TB-500 weekly for Chronic tendinopathy; BPC 3-4x weekly, TB-500 fortnightly for Maintenance after recovery.
TB-500: Not FDA approved for human use. Wolverine Blend (BPC-157 + TB-500): Neither component is FDA approved for human use. FDA issued a warning letter in 2024 regarding compounded BPC-157 products.
Log doses, automate injection site rotation, and never lose track of where you last pinned. Free forever.
Get Started Free